424 related articles for article (PubMed ID: 11123427)
1. Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopoietic cells.
Yamada K; Yajima T; Yagihashi A; Kobayashi D; Koyanagi Y; Asanuma K; Yamada M; Moriai R; Kameshima H; Watanabe N
Jpn J Cancer Res; 2000 Dec; 91(12):1278-84. PubMed ID: 11123427
[TBL] [Abstract][Full Text] [Related]
2. [Telomerase, cell immortality and cancer].
Watanabe N
Hokkaido Igaku Zasshi; 2001 May; 76(3):127-32. PubMed ID: 11481865
[TBL] [Abstract][Full Text] [Related]
3. Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells.
Yajima T; Yagihashi A; Kameshima H; Kobayashi D; Hirata K; Watanabe N
Br J Cancer; 2001 Sep; 85(5):752-7. PubMed ID: 11531263
[TBL] [Abstract][Full Text] [Related]
4. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
[TBL] [Abstract][Full Text] [Related]
5. Impaired telomere regulation mechanism by TRF1 (telomere-binding protein), but not TRF2 expression, in acute leukemia cells.
Ohyashiki JH; Hayashi S; Yahata N; Iwama H; Ando K; Tauchi T; Ohyashiki K
Int J Oncol; 2001 Mar; 18(3):593-8. PubMed ID: 11179492
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity is down regulated via decreases in hTERT mRNA but not TEP1 mRNA or hTERC during the differentiation of leukemic cells.
Koyanagi Y; Kobayashi D; Yajima T; Asanuma K; Kimura T; Sato T; Kida T; Yagihashi A; Kameshima H; Watanabe N
Anticancer Res; 2000; 20(2A):773-8. PubMed ID: 10810353
[TBL] [Abstract][Full Text] [Related]
7. Decreased gene expression for telomeric-repeat binding factors and TIN2 in malignant hematopoietic cells.
Yamada K; Yagihashi A; Yamada M; Asanuma K; Moriai R; Kobayashi D; Tsuji N; Watanabe N
Anticancer Res; 2002; 22(2B):1315-20. PubMed ID: 12168944
[TBL] [Abstract][Full Text] [Related]
8. hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia.
Campbell LJ; Fidler C; Eagleton H; Peniket A; Kusec R; Gal S; Littlewood TJ; Wainscoat JS; Boultwood J
Leukemia; 2006 Apr; 20(4):671-9. PubMed ID: 16498395
[TBL] [Abstract][Full Text] [Related]
9. Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Kitadai Y; Haruma K; Chayama K; Tahara E; Yasui W
Pathobiology; 2001; 69(4):219-24. PubMed ID: 12007281
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy.
Engelhardt M; Ozkaynak MF; Drullinsky P; Sandoval C; Tugal O; Jayabose S; Moore MA
Leukemia; 1998 Jan; 12(1):13-24. PubMed ID: 9436916
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation.
Klapper W; Krams M; Qian W; Janssen D; Parwaresch R
Br J Cancer; 2003 Aug; 89(4):713-9. PubMed ID: 12915884
[TBL] [Abstract][Full Text] [Related]
12. Quantitative relationship between functionally active telomerase and major telomerase components (hTERT and hTR) in acute leukaemia cells.
Ohyashiki JH; Hisatomi H; Nagao K; Honda S; Takaku T; Zhang Y; Sashida G; Ohyashiki K
Br J Cancer; 2005 May; 92(10):1942-7. PubMed ID: 15827550
[TBL] [Abstract][Full Text] [Related]
13. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.
Butler KS; Hines WC; Heaphy CM; Griffith JK
Cancer Med; 2012 Oct; 1(2):165-75. PubMed ID: 23342266
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression of human telomerase-associated protein hTERT and TEP1 in human hematopoietic cells.
Uchida N; Otsuka T; Shigematsu H; Maeda M; Sugio Y; Itoh Y; Niho Y
Leuk Res; 1999 Dec; 23(12):1127-32. PubMed ID: 10613358
[TBL] [Abstract][Full Text] [Related]
15. A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes.
Escoffier E; Rezza A; Roborel de Climens A; Belleville A; Gazzolo L; Gilson E; Duc Dodon M
Retrovirology; 2005 Dec; 2():77. PubMed ID: 16354306
[TBL] [Abstract][Full Text] [Related]
16. The expression of telomeric proteins and their probable regulation of telomerase during the differentiation of all-trans-retinoic acid-responsive and -resistant acute promyelocytic leukemia cells.
Sun J; Huang H; Zhu Y; Lan J; Li J; Lai X; Yu J
Int J Hematol; 2005 Oct; 82(3):215-23. PubMed ID: 16207594
[TBL] [Abstract][Full Text] [Related]
17. [Expression of human telomere repeat binding factor 1 (TRF1) in acute leukemia cells and its correlation with telomerase activities].
Sun J; Lai XY; Zhu YY; Lan JP; Tang LD; Li JY; Yu J; Tan YM; Lin MF; Huang H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 33(6):491-5. PubMed ID: 15586404
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of telomerase related proteins in human normal oral and ectocervical epithelial cells.
Fujimoto R; Kamata N; Taki M; Yokoyama K; Tomonari M; Nagayama M; Yasumoto S
Oral Oncol; 2003 Jul; 39(5):445-52. PubMed ID: 12747968
[TBL] [Abstract][Full Text] [Related]
19. Control of human telomere length by TRF1 and TRF2.
Smogorzewska A; van Steensel B; Bianchi A; Oelmann S; Schaefer MR; Schnapp G; de Lange T
Mol Cell Biol; 2000 Mar; 20(5):1659-68. PubMed ID: 10669743
[TBL] [Abstract][Full Text] [Related]
20. Mild hyperoxia limits hTR levels, telomerase activity, and telomere length maintenance in hTERT-transduced bone marrow endothelial cells.
Napier CE; Veas LA; Kan CY; Taylor LM; Yuan J; Wen VW; James A; O'Brien TA; Lock RB; MacKenzie KL
Biochim Biophys Acta; 2010 Oct; 1803(10):1142-53. PubMed ID: 20619302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
